MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Perrigo (NY: PRGO )

26.92 -0.99 (-3.55%)
Official Closing Price Updated: 7:00 PM EDT, Aug 9, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,309,042
Open 27.89
Bid (Size) 26.70 (1)
Ask (Size) 26.96 (10)
Prev. Close 27.91
Today's Range 26.66 - 27.89
52wk Range 24.82 - 39.40
Shares Outstanding 136,400,000
Dividend Yield 4.06%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
PRGO Stock Earnings: Perrigo Beats EPS, Misses Revenue for Q2 2024
PRGO stock results show that Perrigo beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace
Abbott Labs (ABT) Stock Falls on Baby Formula Ruling. What to Know.
ABT stock is in focus on ruling news. Abbott faced a suit last year over the closing of its Michigan plant resulting in a formula shortage. 
Via InvestorPlace

Performance

YTD
-18.84%
-18.84%
1 Month
-2.04%
-2.04%
3 Month
-12.60%
-12.60%
6 Month
-16.91%
-16.91%
1 Year
-30.92%
-30.92%

More News

Read More
AbbVie Appeals To Supreme Court Over Attorney-Client Privilege In 'Long-Standing' AndroGel Case
Via Benzinga
$20M Bet On This Energy Stock? Check Out These 3 Stocks Insiders Are Buying
Via Benzinga
PRGO Stock Earnings: Perrigo Beats EPS, Misses Revenue for Q1 2024
Via InvestorPlace
Disney To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
Earnings Scheduled For February 27, 2024
Via Benzinga
Perrigo Supports Customers through Tough Times, Supporting Shareholders through Changes
Via Benzinga
Why Beyond Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
CVS Health's Zero-Cost Coverage Paves Way For OTC Birth Control Access
Via Benzinga
Preview: Perrigo's Earnings
Via Benzinga
Perrigo Supports Customers through Tough Times, Supporting Shareholders through Changes
Via Benzinga
Hidden Gems: 3 Market Underdogs to Buy at Rock-Bottom Prices
Via InvestorPlace
Around $2M Bet On Tile Shop Holdings? Check Out These 4 Stocks Insiders Are Buying
Via Benzinga
Stocks Mixed As Consumer Confidence Falls
Via Talk Markets
OTC Medicine Player Perrigo Outlines Three-Year Cost Saving Plan, Posts Mixed Q4 Earnings
Via Benzinga
Insiders bet big on these turnaround stocks
Via MarketBeat
Topics Economy Initial Public Offering
Exposures Interest Rates Securities Market
Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Insiders Buying DENTSPLY SIRONA And 2 Other Stocks
Via Benzinga
$1.8M Bet On This Stock? Check Out These 3 Stocks Insiders Are Buying
Via Benzinga
Personal Care Industry Poised For Growth: Analyst Initiates Coverage On These 3 Stocks
Via Benzinga
Perrigo Cuts Annual Guidance, This OTC Drug Firm Also Reports Mixed Q3 Earnings
Via Benzinga
Cramer Says This AI Company 'Actually Lived Up To Their Hype': Stock Is Up 148% This Year
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
With a Big Catalyst in Hand, Is Perrigo Company a Buy?
Via The Motley Fool
Earnings Scheduled For November 7, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
TOP
Email a Story